BlackRock, Inc. 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 10:29 am Sale | 2025-03-31 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 35,907,601 15.100% | -2,361,833 (-6.17%) | Filing |
| 2024-10-07 4:08 pm Purchase | 2024-09-30 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 38,269,434 16.400% | 20,351,689 (+113.58%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 17,917,745 7.900% | 2,816,464 (+18.65%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 15,101,281 6.900% | 9,347,461 (+162.46%) | Filing |